SCHEMBL1028908

SCHEMBL1028908

O=[C]CCCCF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6068254 0.97
SCHEMBL7755001 0.97
SCHEMBL8813065 0.97
SCHEMBL8811092 0.97
SCHEMBL10727707 0.97
SCHEMBL1721209 0.97
SCHEMBL1048370 0.90
SCHEMBL131287 0.82
SCHEMBL2153675 0.78
SCHEMBL2153961 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 181 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024117205-A1 BICYCLIC PYRIDINE DERIVATIVE AND SALT THEREOF, AND HARMFUL ORGANISM CONTROL AGENT CHARACTERIZED BY CONTAINING SAID DERIVATIVE OR SALT THEREOF AS ACTIVE INGREDIENT 北興化学工業株式会社 2024-06-06 WO disclosed
CN-114732822-B Application of glucosamine and derivatives thereof as antiviral drugs 中国人民解放军军事科学院军事医学研究院 2023-06-30 CN disclosed
CN-114681472-B Application of glucosamine and derivatives thereof as antiviral drugs 中国人民解放军军事科学院军事医学研究院 2023-06-30 CN disclosed
CN-114732823-B Application of glucosamine and derivatives thereof as antiviral drugs 中国人民解放军军事科学院军事医学研究院 2023-05-23 CN disclosed
CN-114732822-A Application of glucosamine and derivatives thereof as antiviral drugs 中国人民解放军军事科学院军事医学研究院 2022-07-12 CN disclosed
CN-114732823-A Application of glucosamine and derivatives thereof as antiviral drugs 中国人民解放军军事科学院军事医学研究院 2022-07-12 CN disclosed
CN-114681472-A Application of glucosamine and derivatives thereof as antiviral drugs 中国人民解放军军事科学院军事医学研究院 2022-07-01 CN disclosed
CN-109771432-B Application of glucosamine and derivatives thereof as antiviral drugs 中国人民解放军军事科学院军事医学研究院 2022-04-19 CN disclosed
US-20210171822-A1 IN SITU H2S SCAVENGER ADDITIVE GENERATION HALLIBURTON ENERGY SERVICES, INC. (US) 2021-06-10 US disclosed
US-11008504-B1 In situ H2S scavenger additive generation HALLIBURTON ENERGY SERVICES, INC. (US) 2021-05-18 US disclosed
WO-1998012182-A1 1-SULFONYL-3-PHENYLPYRAZOLES AND THEIR USE AS HERBICIDES AND FOR DESICCATING OR DEFOLIATING PLANTS BASF AKTIENGESELLSCHAFT (DE) 1998-03-26 WO disclosed
WO-1998005649-A1 SUBSTITUTED 3-PHENYL PYRAZOLES BASF AKTIENGESELLSCHAFT (DE) 1998-02-12 WO disclosed
WO-1997035845-A1 SUBSTITUTED 1-METHYL-3-BENZYLURACILS BASF AKTIENGESELLSCHAFT (DE) 1997-10-02 WO disclosed
WO-1997030059-A1 SUBSTITUTED 2-PHENYLPYRIDINES BASF AKTIENGESELLSCHAFT (DE) 1997-08-21 WO disclosed
WO-1997001543-A1 1-AMINO-3-BENZYLURACILS BASF AKTIENGESELLSCHAFT (DE) 1997-01-16 WO disclosed
US-5470851-A Antihistamine, anticoagulants SANKYO COMPANY, LIMITED (JP) 1995-11-28 US disclosed
US-5436242-A Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof for inhibiting blood platelet aggregation SANKYO COMPANY, LIMITED (JP) 1995-07-25 US disclosed
US-5288726-A Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation UBE INDUSTRIES LIMITED (JP) 1994-02-22 US disclosed
EP-0542411-A2 Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation Sankyo Company Limited (JP) 1993-05-19 EP disclosed
EP-0463873-A1 Thiazolidinecarboxylic acid amide derivatives having anti-allergic activity, their preparation and their use Sankyo Company Limited (JP) 1992-01-02 EP disclosed